Health Guidance

Preclinical Models: Innovative solutions to accelerate drug discovery and development

Preclinical models are developed to test lead compounds for toxicity and efficacy. They are valuable tools to minimize development costs and reduce failures prior to commencement of human trials. Problems with traditional animal models such as cost, ethics, and suitability has prompted researchers to develop new models and systems to overcome such disadvantages. Continue reading ‘Preclinical Models – Innovative Solutions To Accelerate Drug Discovery And Development’ »

Major developments are likely in both the IVD market and in imaging-based modalities, like computed tomography, with the emphasis being upon the personalized medicine approach, where demand will come from physicians, patients and payors – all of whom want more effective treatments and value for money.

This report analyzes the latest innovations in oncology diagnostics and identifies the most exciting new technologies and trends, ranging from body imaging and cytology to molecular diagnostics and pharmacogenomics. The report also identifies the key challenges facing innovative diagnostics companies.

Key Features of this report

•Analysis the latest innovations in diagnostics imaging in the oncology sector, covering Magnetic Resonance Imaging (MRI), x-ray, Computed Tomography (CT), ultrasound, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) and Flow Cytometry.
•Analyzes the latest innovations in molecular diagnostics and how they impact the diagnostics market. The report covers technology including fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), HPV testing, immunoassays & biomarkers, microarrays and comparative genomic hybridization (CGH). Continue reading ‘Innovations In Oncology Diagnostics: Technological Advances, Growth Opportunities And Future Market Outlook’ »

Bharatbook.com added a new report on “Alliance Pharma plc-Company Report” into its market report catalogue for reselling.

Alliance Pharma plc-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Continue reading ‘Alliance Pharma plc-Company Report By: Bharat Book Bureau Alliance Pharma plc-Company Report Bharatbook.com added a new report on "Alliance Pharma plc-Company Report" into its market report catalogue for reselling. Alliance Pharma plc-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies. Scope of the reports Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company's management team and its products. . Key benefits * Private Company Reports deliver independent insight into a company''s operations and products – vital intelligence for investors, competitors and partners. * Save both time and money by instantly accessing private company data that can be difficult to source independently. To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=137058&rt=Alliance-Pharma-plc-Company-Report.htmlOr Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/3bbharatbook <!– p {margin-right:0in; margin-left:0in; font-size:12.0pt; font-family:"Times New Roman","serif"; } –> Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies. About the Author Bharat Book Bureau, the leading market research information aggregator provides reports, company profiles, newsletters, country info. and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our reports help global companies to know different market before starting up business / expanding in different countries across the world.(ArticlesBase SC #2615582) Article Source: http://www.articlesbase.com/ – Alliance Pharma plc-Company Report’ »

Intercell AG-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Intercell AG-Company Report’ »

US healthcare reform: a double-edged sword

The US House of Representatives has passed legislation paving the way for major healthcare system reform designed to substantially decrease the number of individuals without health insurance. Despite its potential benefits, it believes that the reform is a mixed blessing for the pharmaceutical industry as cost-containment pressures are set to intensify in the long term. ( http://www.bharatbook.com/detail.asp?id=134206&rt=Pharmaceutical-Licensing-Overview.html )

The landmark bill will overhaul the US healthcare system, aiming to reduce the number of individuals without healthcare insurance, improve access to healthcare and curb escalating costs. The bill focuses on health insurance system reform, specifically: expanding Medicaid insurance coverage for the poor; implementing stricter rules for private health insurers; outlining the creation of an individual mandate to purchase insurance; and introducing health insurance premium subsidies. Continue reading ‘US healthcare reform: a double-edged sword’ »

Incoming search terms:

• obama\s double sided sword on health care (2)

HTML clipboard

The Kenya Pharmaceuticals and Healthcare Report

Independent 5-year pharmaceutical and healthcare industry forecasts for Kenya. Original pharmaceutical and healthcare market research and pharmaceutical and healthcare sector trend analysis for the Kenyan pharmaceutical and healthcare industry. Competitive intelligence, Kenyan pharmaceutical and healthcare company rankings and SWOT analyses on international and domestic pharmaceutical and healthcare companies in the Kenyan market. ( http://www.bharatbook.com/Market-Research-Reports/Pharmaceuticals-Healthcare-Report-Kenya.html )

The Kenya Pharmaceuticals and Healthcare Report has been researched at source and features the latest available data and forecasts to end- covering drugs and healthcare expenditure, the prescription, OTC and generics markets, and foreign trade; company rankings and competitive landscapes including multinational and national drugs companies; and analysis of latest industry news, trends and regulatory developments. Kenya Pharmaceuticals and Healthcare Report provides industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Kenyan pharmaceutical and healthcare industry.

Key Benefits of Report :

* Benchmark Independent 5-year Pharmaceutical and Healthcare Industry Forecasts on Kenya to test other views – a key input for successful budgeting and strategic business planning in the Kenyan pharmaceutical and healthcare market. Continue reading ‘Opportunities & Risks in the Kenyan Pharmaceutical and Healthcare Sector’ »

Incoming search terms:

• the global pharmaceutical industry swallowing a bitter pill (6)
• swot analysis the global pharmaceutical industry swallowing a bitter pill (4)
• kenya pharma market (4)
• swot analysis of health care system of kenya (4)
• pharmaceutical competitors of kenya (2)
• REGULATION OF THE PHARMACEUTICAL INDUSTRY IN KENYA (2)
• swot analysis of health care in kenya (2)
• swot analysis pharmaceutical industry in kenya (2)
• business opportunities and risks in natural skin care industry (2)
• swot analysis the global pharmaceutical industry: swallowing a bitter pill (2)
• the global pharmaceutical industry swallowing a bitter pill pestel analysis (2)
• the global pharmaceutical industry: swallowing a bitter pill PESTEL (2)
• pharmaceutical analysts in kenya (2)
• Pharma market trend in Kenya (2)
• pestel analysis the global pharmaceutical industry swallowing a bitter pill (2)

Global healthcare market is evolving from traditional healthcare system to modern healthcare system of E-health which minimizes the physical movement of patients and enhances the coverage of healthcare services. As the world population is aging, it has resulted in increase of global healthcare expenditure. The major increase in healthcare expenditure is being witnessed in developed nations where population is ageing at a higher pace compared to less developed nations. Aging population has resulted in increase in demand of healthcare services which is already in an over-pressurized state.

It is now believed that telemedicine is going to be an important component of the modern healthcare system which will ease the pressure over the existing healthcare system which is suffering from problems like lack of required number of physicians, high cost and limited reach in the rural areas. Telemedicine, being a component of E-health, is a provision of healthcare services that uses telecommunication technology and multimedia equipment to provide healthcare solutions over a geographic distance. Continue reading ‘New Report "analysis Of Telemedicine Market" Available Through Aarkstore Enterprise’ »

Oncothyreon, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication. Continue reading ‘Oncothyreon, Inc.-Therapeutic Competitors’ »

Axcan Pharma Inc.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Axcan Pharma Inc.-Company Report’ »

Bausch & Lomb Incorporated-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Bausch & Lomb Incorporated-Company Report’ »